Common Stock, Shares, Outstanding of KYNTRA BIO, INC. from 31 Dec 2014 to 30 Sep 2025

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
KYNTRA BIO, INC. quarterly Common Stock, Shares, Outstanding in shares history and change rate from 31 Dec 2014 to 30 Sep 2025.
  • KYNTRA BIO, INC. Common Stock, Shares, Outstanding for the quarter ending 30 Sep 2025 was 4,045,000, a 96% decline year-over-year.
Source SEC data
View on sec.gov
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Change (%)

KYNTRA BIO, INC. Quarterly Common Stock, Shares, Outstanding (shares)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2025 4,045,000 -96,725,000 -96% 30 Sep 2025 10-Q 10 Nov 2025 2025 Q3
Q2 2025 4,044,000 -96,356,000 -96% 30 Jun 2025 10-Q 11 Aug 2025 2025 Q2
Q1 2025 101,044,000 +1,570,000 +1.6% 31 Mar 2025 10-Q 12 May 2025 2025 Q1
Q4 2024 4,037,000 -94,733,000 -96% 31 Dec 2024 10-Q 10 Nov 2025 2025 Q3
Q3 2024 100,770,000 +2,431,000 +2.5% 30 Sep 2024 10-Q 12 Nov 2024 2024 Q3
Q2 2024 100,400,000 +2,196,000 +2.2% 30 Jun 2024 10-Q 06 Aug 2024 2024 Q2
Q1 2024 99,474,000 +2,851,000 +3% 31 Mar 2024 10-Q 06 May 2024 2024 Q1
Q4 2023 98,770,000 +4,604,000 +4.9% 31 Dec 2023 10-K 17 Mar 2025 2024 FY
Q3 2023 98,339,000 +4,403,000 +4.7% 30 Sep 2023 10-Q 06 Nov 2023 2023 Q3
Q2 2023 98,204,000 +4,471,000 +4.8% 30 Jun 2023 10-Q 07 Aug 2023 2023 Q2
Q1 2023 96,623,000 +3,334,000 +3.6% 31 Mar 2023 10-Q 08 May 2023 2023 Q1
Q4 2022 94,166,000 +1,285,000 +1.4% 31 Dec 2022 10-K 26 Feb 2024 2023 FY
Q3 2022 93,936,000 +1,228,000 +1.3% 30 Sep 2022 10-Q 07 Nov 2022 2022 Q3
Q2 2022 93,733,000 +1,124,000 +1.2% 30 Jun 2022 10-Q 08 Aug 2022 2022 Q2
Q1 2022 93,289,000 +1,209,000 +1.3% 31 Mar 2022 10-Q 09 May 2022 2022 Q1
Q4 2021 92,881,000 +1,440,000 +1.6% 31 Dec 2021 10-K 27 Feb 2023 2022 FY
Q3 2021 92,708,000 +1,823,000 +2% 30 Sep 2021 10-Q 09 Nov 2021 2021 Q3
Q2 2021 92,609,000 +2,381,000 +2.6% 30 Jun 2021 10-Q 09 Aug 2021 2021 Q2
Q1 2021 92,080,000 +3,184,000 +3.6% 31 Mar 2021 10-Q 10 May 2021 2021 Q1
Q4 2020 91,441,000 +3,784,000 +4.3% 31 Dec 2020 10-K/A 04 Mar 2022 2021 FY
Q3 2020 90,885,000 +3,674,000 +4.2% 30 Sep 2020 10-Q 05 Nov 2020 2019 Q3
Q2 2020 90,228,000 +3,381,000 +3.9% 30 Jun 2020 10-Q 06 Aug 2020 2019 Q2
Q1 2020 88,896,000 +2,766,000 +3.2% 31 Mar 2020 10-Q 07 May 2020 2019 Q1
Q4 2019 87,657,000 +2,225,000 +2.6% 31 Dec 2019 10-K 01 Mar 2021 2020 FY
Q3 2019 87,211,000 +2,364,000 +2.8% 30 Sep 2019 10-Q 12 Nov 2019 2019 Q3
Q2 2019 86,847,000 +2,664,000 +3.2% 30 Jun 2019 10-Q 08 Aug 2019 2019 Q2
Q1 2019 86,130,000 +2,709,000 +3.2% 31 Mar 2019 10-Q 09 May 2019 2019 Q1
Q4 2018 85,432,000 +2,934,000 +3.6% 31 Dec 2018 10-K 02 Mar 2020 2019 FY
Q3 2018 84,847,000 +3,033,000 +3.7% 30 Sep 2018 10-Q 08 Nov 2018 2018 Q3
Q2 2018 84,183,000 +13,214,000 +19% 30 Jun 2018 10-Q 07 Aug 2018 2018 Q2
Q1 2018 83,421,000 +18,999,000 +29% 31 Mar 2018 10-Q 09 May 2018 2018 Q1
Q4 2017 82,498,000 +18,833,000 +30% 31 Dec 2017 10-K 27 Feb 2019 2018 FY
Q3 2017 81,814,000 +18,739,000 +30% 30 Sep 2017 10-Q 08 Nov 2017 2017 Q3
Q2 2017 70,969,000 +8,227,000 +13% 30 Jun 2017 10-Q 07 Aug 2017 2017 Q2
Q1 2017 64,422,000 +1,997,000 +3.2% 31 Mar 2017 10-Q 09 May 2017 2017 Q1
Q4 2016 63,665,000 +1,680,000 +2.7% 31 Dec 2016 10-K 27 Feb 2018 2017 FY
Q3 2016 63,075,000 +1,835,000 +3% 30 Sep 2016 10-Q 08 Nov 2016 2016 Q3
Q2 2016 62,742,000 +2,372,000 +3.9% 30 Jun 2016 10-Q 08 Aug 2016 2016 Q2
Q1 2016 62,425,000 +3,157,000 +5.3% 31 Mar 2016 10-Q 09 May 2016 2016 Q1
Q4 2015 61,985,000 +2,939,000 +5% 31 Dec 2015 10-K 01 Mar 2017 2016 FY
Q3 2015 61,240,000 30 Sep 2015 10-Q 12 Nov 2015 2015 Q3
Q2 2015 60,370,000 30 Jun 2015 10-Q 13 Aug 2015 2015 Q2
Q1 2015 59,268,000 31 Mar 2015 10-Q 12 May 2015 2015 Q1
Q4 2014 59,046,000 31 Dec 2014 10-K 29 Feb 2016 2015 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.